← Back to Patent Explorer
US4374847A Expired / Lapsed US ⏱️ 0.0 years remaining

1-Carboxyalkanoylindoline-2-carboxylic acids

Assignee: Novartis Corp
•
Filing: 1981-02-17
•
Granted: 1983-02-22
•
Expires: 2001-02-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-Carboxy-(alkanoyl or aralkanoyl)-indoline-2-carboxylic acids, e.g., those of the formula <IMAGE> R=H, alkyl, alkoxy, halogeno or CF3; R'=H or R-phenyl; m=0 or 1; p,q=0 to 2; and functional derivatives thereof, are antihypertensive and cardioactive agents.

Inventors

  • 👤 Norbert Gruenfeld

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 18:14
CPC Classifications
C; C07; C07D; C07D209/00; C07D209/02; C07D209/04; C07D209/30; C07D209/42

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 94 words
A 1-carboxy-(alkanoyl or aralkanoyl)-indoline-2-carboxylic acid compound of the formula: ##STR17## wherein Ph is unsubstituted 1,2-phenylene, or 1,2-phenylene substituted by one to three identical or different members selected from lower alkyl, lower alkoxy, lower alkylenedioxy, hydroxy, halogeno and trifluoromethyl; R o is hydrogen or HPh; each of R 1 , R 2 and R 3 is hydrogen or lower alkyl; and n is an integer from 2 to 8; an amide, mono- or di-lower alkylamide, lower alkyl ester, (amino, mono- or di-lower alkylamino, carboxy or lower carbalkoxy)-lower alkyl ester, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 94 words
A 1-carboxy-(alkanoyl or aralkanoyl)-indoline-2-carboxylic acid compound of the formula: ##STR17## wherein Ph is unsubstituted 1,2-phenylene, or 1,2-phenylene substituted by one to three identical or different members selected from lower alkyl, lower alkoxy, lower alkylenedioxy, hydroxy, halogeno and trifluoromethyl; R o is hydrogen or HPh; each of R 1 , R 2 and R 3 is hydrogen or lower alkyl; and n is an integer from 2 to 8; an amide, mono- or di-lower alkylamide, lower alkyl ester, (amino, mono- or di-lower alkylamino, carboxy or lower carbalkoxy)-lower alkyl ester, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 119 words
A compound as claimed in claim 1, in which formula Ph is unsubstituted 1,2-phenylene, or 1,2-phenylene substituted by one or two identical or different members selected from lower alkyl, lower alkoxy, hydroxy and halogeno, or 1,2-phenylene substituted by one lower alkylenedioxy or trifluoromethyl group; R o is hydrogen or HPh; each of R 1 , R 2 and R 3 is hydrogen or lower alkyl; and n is an integer from 2 to 8; an amide, mono- or di-lower alkylamide, a lower alkyl ester, (amino, mono- or di-lower alkylamino, carboxy or lower carbalkoxy)-lower alkyl ester; or a pharmaceutically acceptable alkali metal, alkaline earth metal or ammonium salt of said acid, or an acid addition salt of said aminoalkyl ester.
Claim 4
Dependent Claim 63 words
A compound as claimed in claim 2, wherein Ph is 1,2-phenylene, unsubstituted or mono-substituted by lower alkyl, lower alkoxy, lower alkylenedioxy, hydroxy, halogeno or trifluoromethyl; R o is hydrogen or HPh; each R 1 , R 2 and R 3 is hydrogen or methyl; and n is an integer from 2 to 8; or said acid or amino derivatives listed in claim 2.
Claim 5
Dependent Claim 86 words
A compound as claimed in claim 2 and corresponding to the formula: ##STR18## wherein R is hydrogen, alkyl or alkoxy with up to 4 carbon atoms, halogeno or trifluoromethyl; m is the integer 0 or 1; each of p and q is an integer from 0 to 2; and R' is hydrogen or R-phenyl; a mono- or bis-amide, the mono- or bis-lower (alkyl or ω-aminoalkyl) ester, a pharmaceutically acceptable alkali metal or ammonium salt of said acid, or an acid addition salt of said aminoalkyl ester.
Claim 6
Dependent Claim 52 words
A compound as claimed in claim 4, in which formula R is hydrogen, methyl, methoxy, fluoro, chloro or trifluoromethyl; each of m and p is the integer 1; q is the integer 1 or 2; and R' is hydrogen or phenyl, or a said acid or amino derivative listed in claim 4.
Claim 7
Dependent Claim 13 words
A compound as claimed in claim 4, wherein R is in the 5-indoline-position.
Claim 8
Dependent Claim 15 words
A compound as claimed in claim 4, in the form of its 2S-carboxy-indoline chiral epimer.
Claim 9
Dependent Claim 12 words
1-(2,4-dimethyl-4-carboxybutanoyl)-indoline-2S-carboxylic acid; or a pharmaceutically acceptable alkali metal or ammonium salt thereof.
Claim 10
Dependent Claim 12 words
1-(2,4-dimethyl-4-carboxybutanoyl)-indoline-2S-carboxylic acid; or a pharmaceutically acceptable alkali metal or ammonium salt thereof.
Claim 11
Dependent Claim 11 words
1-[4-carboxy-4-(2-phenethyl)-butanoyl]-indoline-2S-carboxylic acid; or a pharmaceutically acceptable metal or ammonium salt thereof.
Claim 12
Dependent Claim 11 words
1-[4-carboxy-4-(2-phenethyl)-butanoyl]-indoline-2S-carboxylic acid; or a pharmaceutically acceptable metal or ammonium salt thereof.
Claim 13
Dependent Claim 22 words
A compound as claimed in claim 7, and being the 1-(4-carboethoxy-2R,4R-dimethylbutanoyl)-indoline-2S-carboxylic acid; or a pharmaceutically acceptable alkali metal or ammonium salt thereof.
Claim 14
Dependent Claim 22 words
A compound as claimed in claim 7, and being the 1-(4-carboxy-2R,4R-dimethylbutanoyl)-indoline-2S-carboxylic acid; or a pharmaceutically acceptable alkali metal or ammonium salt thereof.
Claim 15
Dependent Claim 22 words
A compound as claimed in claim 7, and being the 1-(4-carboethoxy-2R-methylbutanoyl)-indoline-2S-carboxylic acid; or a pharmaceutically acceptable alkali metal or ammonium salt thereof.
Claim 16
Dependent Claim 22 words
A compound as claimed in claim 7, and being the 1-(4-carboxy-2R-methylbutanoyl)-indoline-2S-carboxylic acid; or a pharmaceutically acceptable alkali metal or ammonium salt thereof.
Claim 17
Dependent Claim 22 words
A compound as claimed in claim 7, and being the 1-(4-carboethoxy-2R-methyl-4R-phenethylbutanoyl)-indoline-2S-carboxylic acid; or a pharmaceutically acceptable alkali metal or ammonium salt thereof.
Claim 18
Dependent Claim 24 words
An antihypertensive and cardioactive pharmaceutical composition comprising a correspondingly effective amount of a compound as claimed in claim 1, together with a pharmaceutical excipient.
Claim 19
Dependent Claim 31 words
A method of treating hypertension or congestive heart failure in mammals, which consists in administering to said mammals in need thereof, an effective amount of a composition claimed in claim 15.
Claim 20
Dependent Claim 16 words
A compound as claimed in claim 4 wherein the chirality corresponds to the formula IIa: ##STR19##

References Cited (Backward Citations)

US3974145A Cited
US3780062A Cited
US3796723A Cited
US4046889A Cited
US4052511A Cited
US4154937A Cited
EP0024852A1 Cited
US4303583A Cited
EP0037231A2 Cited
US4311705A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-02-21 1986-08-23 1987-02-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-02-21 1990-08-23 1991-02-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-02-21 1994-08-23 1995-02-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag